Quarterly report pursuant to Section 13 or 15(d)

Avinza Co-Promotion (Tables)

v2.4.0.8
Avinza Co-Promotion (Tables)
9 Months Ended
Sep. 30, 2014
Co Promotion [Abstract]  
Summary of co-promote termination liability
A summary of the co-promote termination liability as of September 30, 2014 is as follows (in thousands):

Net present value of payments based on estimated future net Avinza product sales as of December 31, 2013
$
11,746

Assumed payments made by Pfizer or assignee
(1,002
)
Fair value adjustments
(10,221
)
Total co-promote termination liability as of September 30, 2014
$
523